Sponsor or institution
Clinical trials and research at Tortugas Neuroscience, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Tortugas Neuroscience, Inc. that are recruiting, at sites in 2 countries (most in New Zealand (2), Australia (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
A single-dose tablet of TRTL-729 tested in healthy adults
A single-dose tablet form of TRTL-729 is being tested in healthy adults to see if it is safe, tolerated, and how the body processes it.
-
TRTL-913 in adults with tinnitus: safety and signals of benefit
This trial tests TRTL-913 versus placebo in healthy adults and in adults with tinnitus to see if it is safe, tolerable, and potentially helpful for tinnitus patients.
Quick answers
How many clinical trials run by Tortugas Neuroscience, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in New Zealand (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.